AhR ligand-activated pathways mediate anticancer activities in breast cancer cells
AhR ligand-activated pathways mediate anticancer activities in breast cancer cells. In triple-negative breast cancer cells, the tumor suppressor characteristics exhibited by different types of AhR ligand may be related to the downregulation of CXCR4, the miR-212/132/SOX4 signaling axis, the JAG1/NOTCH1 signaling pathway and the TGF-β signaling pathway. In estrogen receptor-positive breast cancer cells, the tumor-suppressive characteristics of different types of AhR ligand may be associated with the activation of the MAPK/ERK signaling pathway and the inhibition of the PI3K/AKT signaling pathway, FAK and the expression of MMPs. In addition, a number of AhR ligands may disrupt the interaction between CDK4 and AhR to induce cell cycle arrest in breast cancer cells. (a) The signal pathway involved in AhR ligand in TNBC cells, such as MDA-MB-231 cells. (b) The signal pathway involved in AhR ligand in ER-positive breast cancer cells, such as MCF-7 cells. β-NF, β-naphthoflavone; AF, aminoflavone; AhR, aryl hydrocarbon receptor; ARNT, AhR nuclear translocator; CXCR4, C-X-C motif chemokine receptor 4; CYP1A1, cytochrome P450 family 1 subfamily A member 1; CYP1A2, cytochrome P450 family 1 subfamily A member 2; CYP1B1, cytochrome P450 family 1 subfamily B member 1; DIM, 3,3-diindolylmethane; FAK, focal adhesion kinase; FICZ, 6-formylindolo(3,2-b) carbazole; I3C, indole-3-carbinol; ICZ, indole (3,2-b) carbazole; ITE, 2-(1′h-indole-3′-carbonyl)-thiazole-4-carboxylic acid; JAG1, jagged canonical Notch ligand 1; miR, microRNA; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; XRE, xenobiotic response elements
Publication
Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target (Review) (2024) Cong Chen, et al. Mol Med Rep. 2024 Jan;29(1). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CDK4 | CDK4 | ncbigene_symbol | CDK4 | 1019 |
| Homo sapiens | Primates | AhR | AHR | ncbigene_symbol | AHR | 196 |
| Homo sapiens | Primates | ARNT | ARNT | ncbigene_symbol | ARNT | 405 |
| Homo sapiens | Primates | ARNT | ARNT | ncbigene_synonym | MIA3 | 375056 |
| Homo sapiens | Primates | miR-212 | MIR-212 | ncbigene_synonym | MIR212 | 406994 |
| Homo sapiens | Primates | SOX4 | SOX4 | ncbigene_symbol | SOX4 | 6659 |
| Homo sapiens | Primates | NOTCH1 | NOTCH1 | ncbigene_symbol | NOTCH1 | 4851 |
| Homo sapiens | Primates | CYP1A1 | CYP1A1 | ncbigene_symbol | CYP1A1 | 1543 |
| Homo sapiens | Primates | CYP1B1- | CYP1B1 | ncbigene_symbol | CYP1B1 | 1545 |
| Homo sapiens | Primates | BAX | BAX | ncbigene_symbol | BAX | 581 |
| Homo sapiens | Primates | CYP1A2 | CYP1A2 | ncbigene_symbol | CYP1A2 | 1544 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK8 | 5599 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | MAPK/ERKsignaling | MAPK | famplex_relations | MAPK10 | 5602 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| TCDD | TCDD | 2,3,7,8-tetrachlorooxanthrene | chebi:28119 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|